TKNO
Price
$5.55
Change
-$0.07 (-1.25%)
Updated
Oct 22, 04:59 PM (EDT)
Capitalization
300.76M
14 days until earnings call
Intraday Buy/Sell Signals
VTRS
Price
$10.41
Change
+$0.02 (+0.19%)
Updated
Oct 22, 04:59 PM (EDT)
Capitalization
12.11B
15 days until earnings call
Intraday Buy/Sell Signals
Interact to see
Advertisement

TKNO vs VTRS

Header iconTKNO vs VTRS Comparison
Open Charts TKNO vs VTRSBanner chart's image
Alpha Teknova
Price$5.55
Change-$0.07 (-1.25%)
Volume$2.41K
Capitalization300.76M
Viatris
Price$10.41
Change+$0.02 (+0.19%)
Volume$236.64K
Capitalization12.11B
TKNO vs VTRS Comparison Chart in %
TKNO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VTRS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
TKNO vs. VTRS commentary
Oct 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TKNO is a Hold and VTRS is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 23, 2025
Stock price -- (TKNO: $5.62 vs. VTRS: $10.39)
Brand notoriety: TKNO and VTRS are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: TKNO: 61% vs. VTRS: 68%
Market capitalization -- TKNO: $300.76M vs. VTRS: $12.11B
TKNO [@Pharmaceuticals: Generic] is valued at $300.76M. VTRS’s [@Pharmaceuticals: Generic] market capitalization is $12.11B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $64.74B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $4.02B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

TKNO’s FA Score shows that 0 FA rating(s) are green whileVTRS’s FA Score has 2 green FA rating(s).

  • TKNO’s FA Score: 0 green, 5 red.
  • VTRS’s FA Score: 2 green, 3 red.
According to our system of comparison, VTRS is a better buy in the long-term than TKNO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

TKNO’s TA Score shows that 6 TA indicator(s) are bullish while VTRS’s TA Score has 5 bullish TA indicator(s).

  • TKNO’s TA Score: 6 bullish, 4 bearish.
  • VTRS’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, TKNO is a better buy in the short-term than VTRS.

Price Growth

TKNO (@Pharmaceuticals: Generic) experienced а +9.13% price change this week, while VTRS (@Pharmaceuticals: Generic) price change was +4.63% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -1.86%. For the same industry, the average monthly price growth was -0.43%, and the average quarterly price growth was +43.41%.

Reported Earning Dates

TKNO is expected to report earnings on Nov 05, 2025.

VTRS is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (-1.86% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VTRS($12.1B) has a higher market cap than TKNO($301M). VTRS YTD gains are higher at: -13.312 vs. TKNO (-32.695). TKNO has higher annual earnings (EBITDA): -14.44M vs. VTRS (-493.3M). VTRS has more cash in the bank: 809M vs. TKNO (24M). TKNO has less debt than VTRS: TKNO (29M) vs VTRS (14.8B). VTRS has higher revenues than TKNO: VTRS (14.1B) vs TKNO (38.9M).
TKNOVTRSTKNO / VTRS
Capitalization301M12.1B2%
EBITDA-14.44M-493.3M3%
Gain YTD-32.695-13.312246%
P/E RatioN/A236.20-
Revenue38.9M14.1B0%
Total Cash24M809M3%
Total Debt29M14.8B0%
FUNDAMENTALS RATINGS
VTRS: Fundamental Ratings
VTRS
OUTLOOK RATING
1..100
26
VALUATION
overvalued / fair valued / undervalued
1..100
11
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
47
P/E GROWTH RATING
1..100
1
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
TKNOVTRS
RSI
ODDS (%)
Bearish Trend 2 days ago
80%
Bullish Trend 3 days ago
78%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
59%
Momentum
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
69%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
62%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
64%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
60%
Advances
ODDS (%)
Bullish Trend 8 days ago
86%
Bullish Trend 2 days ago
68%
Declines
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend about 1 month ago
65%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
68%
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
57%
View a ticker or compare two or three
Interact to see
Advertisement
TKNO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VTRS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
IMCB83.170.30
+0.36%
iShares Morningstar Mid-Cap ETF
EBIZ34.140.08
+0.24%
Global X E-commerce ETF
AIRL34.54N/A
N/A
Themes ETF Trust Themes Airlines ETF
FLRG38.19-0.02
-0.04%
Fidelity U.S. Multifactor ETF
FFDI30.09-0.20
-0.65%
Fidelity Fundamental Developed International ETF

TKNO and

Correlation & Price change

A.I.dvisor tells us that TKNO and AMRX have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that TKNO and AMRX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TKNO
1D Price
Change %
TKNO100%
-2.26%
AMRX - TKNO
33%
Poorly correlated
+0.49%
HROW - TKNO
32%
Poorly correlated
-3.11%
NBIX - TKNO
28%
Poorly correlated
+0.93%
LFCR - TKNO
27%
Poorly correlated
+1.96%
VTRS - TKNO
27%
Poorly correlated
+0.78%
More